naltrexone
What is naltrexone used for?
How does naltrexone work?
When was naltrexone approved for treating opioid dependence?
What are common side effects of naltrexone?
What are emerging applications of naltrexone?
naltrexone, long-acting opioid receptor antagonist used primarily in the treatment of opioid use disorder and alcohol use disorder. Naltrexone works specifically by blocking opioid receptors in the brain, which disrupts the transmission of signals that produce the euphoric, sedative, and rewarding effects associated with the use of opioid drugs and alcohol. By reducing cravings and limiting the reinforcing effects of these substances, naltrexone has become an important pharmacological tool in addiction treatment and relapse prevention.
History and development
Naltrexone is a semisynthetic heteropentacyclic compound developed in the mid-20th century during efforts to create medications capable of counteracting the effects of opioid substances. The compound was first synthesized in the early 1960s by researchers working with Endo Laboratories in Long Island, New York, who were investigating new derivatives related to earlier opioid antagonists. Scientists discovered that the molecule had several advantages over previously known compounds, including being active when taken orally and having a relatively long duration of action, which allowed it to remain effective for many hours after a single dose.
Clinical trials in the 1970s explored the potential of naltrexone as a treatment for opioid dependence, focusing on its ability to block the effects of drugs such as heroin and morphine and thereby reduce the likelihood of relapse. The medication was approved in the United States in 1984 for the treatment of opioid dependence. Later research demonstrated that it could also reduce heavy drinking and relapse in alcohol use disorder, leading to approval for that indication in 1995. In the early 21st century, pharmaceutical advances produced a long-acting injectable formulation, designed to improve adherence by providing therapeutic effects for approximately one month per dose.
" height="20" alt="HEW Logo">
Opioid medications are widely used for pain management and as a component of treatment programs for substance use disorders. These medications are classified into two main categories—agonists and antagonists—which bind to the same opioid receptors in the brain but produce different effects based on the way in which they interact with those receptors.
- Opioid antagonists bind to opioid receptors without activating them, thereby blocking or reversing the effects of agonists. As a result, antagonists are commonly used to treat overdoses. Examples include naloxone and naltrexone.
Mechanism of action
Naltrexone acts primarily by binding to and blocking the activity of opioid receptors in the central nervous system, particularly mu (μ) receptors. These receptors normally respond to both externally administered opioids and naturally occurring endorphins and endogenous opioid signaling. As a result, blocking them prevents the characteristic effects associated with opioid drugs, including euphoria and pain relief. Because alcohol consumption likewise stimulates the brain’s reward pathways partly through endogenous opioid signaling, naltrexone also reduces the rewarding sensations associated with drinking and can diminish the urge to continue drinking. The drug typically is taken as a 50-mg oral tablet once daily, though some treatment plans use intermittent dosing several times per week, and a long-acting injectable formulation may be administered once monthly to improve adherence.
Side effects and risks
Naltrexone is generally considered safe when used under medical supervision, though it can produce side effects. Common reactions include nausea, headache, fatigue, anxiety, insomnia, and gastrointestinal discomfort. Less frequently, individuals may experience dizziness, decreased appetite, or mood changes.
Because naltrexone blocks opioid receptors, it also eliminates the analgesic (pain-relieving) effects of opioid medications. Therefore, in emergency medical situations requiring opioid analgesia, alternative pain-management strategies may be necessary. In addition, if individuals discontinue naltrexone and later resume opioid use, their reduced tolerance can increase the risk of overdose.
Emerging applications
Although the principal role of naltrexone remains grounded in the treatment of substance use disorders, the drug continues to be studied for additional medical applications. Based on its influence on immune and neurochemical pathways, for example, low-dose naltrexone is under investigation as a potential therapy for certain inflammatory and autoimmune diseases, including multiple sclerosis and Crohn disease. Other areas of investigation include chronic pain syndromes, mood disorders, and metabolic conditions. In addition, naltrexone, in combination with bupropion, is approved for chronic weight management in adults who are obese or overweight and have related health conditions.
The trusted destination for professionals, college students, and lifelong learners.
SUBSCRIBE
